Barbara Jean Mazur
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Barbara Jean Mazur.
The EMBO Journal | 1988
Kathleen Y. Lee; Jeffrey Townsend; James M. Tepperman; Margaret Black; C. F. Chui; Barbara Jean Mazur; Pamela Dunsmuir; John Bedbrook
The enzyme acetolactate synthase (ALS) is the target enzyme for the sulfonylurea and imidazolinone herbicides. We describe the isolation and characterization of the ALS genes from two herbicide‐resistant mutants, C3 and S4‐Hra, of Nicotiana tabacum. There are two distinct ALS genes in tobacco which are 0.7% divergent at the amino acid sequence level. The C3 mutant has a single Pro–Gln replacement at amino acid 196 in one ALS gene. This gene is termed the class I gene and is equivalent to the SuRA locus. The S4‐Hra mutant has two amino acid changes in the other ALS gene. This gene is termed the class II gene or the SuRB locus. The S4‐Hra mutant includes a Pro–Ala substitution at amino acid 196 and a Trp–Leu substitution at amino acid 573. Gene reintroduction experiments have confirmed that these amino acid substitutions are responsible for the herbicide resistance phenotypes. Transgenic plants carrying these genes are highly resistant to sulfonylurea herbicide applications.
Nature Biotechnology | 2003
Barbara Jean Mazur
A conference in Potsdam, Germany confirms that plant metabolic profiling is moving from an early focus on technology development to one that also addresses trait discovery.
Nature Biotechnology | 2016
Anu Acharya; Kate Bingham; Jay Bradner; Wylie Burke; R. Alta Charo; Joel R. Cherry; André Choulika; Tony Coles; Robert Cook-Deegan; Stanley T. Crooke; Emilia Díaz; Brent Erickson; L Val Giddings; Sebastian Giwa; Jim Greenwood; Vishal Gulati; Sam Hall; John Harris; Jamie Heywood; Colin Hill; Jeremy M Levin; Adina Mangubat; John Maraganore; Giovanni Mariggi; Barbara Jean Mazur; Amy L. McGuire; Nathalie Moll; Jonathan D. Moreno; Gail Naughton; Lita Nelsen
A selection of individuals from the biotech ecosystem give their views on the challenges facing the sector over the coming years.
Nature Biotechnology | 2016
Anu Acharya; Kate Bingham; Jay Bradner; Wylie Burke; R. Alta Charo; Joel R. Cherry; André Choulika; Tony Coles; Robert Cook-Deegan; Stanley T Crook; Emilia Díaz; Brent Erickson; L Val Giddings; Sebastian Giwa; Jim Greenwood; Vishal Gulati; Sam Hall; John Harris; Jamie Heywood; Colin Hill; Jeremy M Levin; Adina Mangubat; John Maraganore; Giovanni Mariggi; Barbara Jean Mazur; Amy L. McGuire; Nathalie Moll; Jonathan D. Moreno; Gail Naughton; Lita Nelsen
Nat. Biotechnol. 34, 276–283 (2016); published online 10 March 2016; corrected after print 31 March 2016 In the version of this article initially published, Stanley Crookes name was misspelled as “Crook” in the author list. The error has been corrected in the HTML and PDF versions of the article.
Archive | 1987
John R. Bedbrook; Roy Scott Chaleff; Saverio Carl Falco; Barbara Jean Mazur; Chris Somerville; Narendra S. Yadav
Nucleic Acids Research | 1985
Barbara Jean Mazur; Chok-Fun Chui
Nature Biotechnology | 1992
Kathleen D'Halluin; Martien Bossut; Els Bonne; Barbara Jean Mazur; Jan Leemans; Johan Botterman
Proceedings of the National Academy of Sciences of the United States of America | 1982
Barbara Jean Mazur; Chok-Fun Chui
ACS symposium series | 1990
M. E. Hartnett; Chok-Fun Chui; C. J. Mauvais; R. E. Mcdevitt; Susan Knowlton; Julie K. Smith; Saverio Carl Falco; Barbara Jean Mazur
Nature Biotechnology | 1999
Barbara Jean Mazur